Herbal medicines for the treatment of rhinosinusitis: A systematic review

Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 4, 2006, Pages 496-506

  Guo, Ruoling ^a   Canter, Peter H ^a   Ernst, Edzard ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; BI YUAN SHU; BROMELAIN; BUPLEURUM ROOT; CEDAR LEAF OIL; CENTRAL STIMULANT AGENT; CINEOLE; DECONGESTIVE AGENT; DOXYCYCLINE; ECHINACEA EXTRACT; EPHEDRINE; ESBERITOX; ESSENTIAL OIL; EUCALYPTUS OIL; FLUOROURACIL; HERBACEOUS AGENT; MYRTOL; PLACEBO; RADIX SCUTELLARIAE EXTRACT; SALICYLIC ACID; SINUPRET; STEROID; TJ 3; UNCLASSIFIED DRUG; VINCRISTINE; XIAO CHAI HU TANG; XYLOMETAZOLINE;

ABSENCE OF SIDE EFFECTS; ACUTE SINUSITIS; ANAPHYLAXIS; CHRONIC SINUSITIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DATA ANALYSIS; DATA ANALYSIS SOFTWARE; DATA EXTRACTION; DRUG EFFICACY; DRUG SAFETY; GAIT DISORDER; GASTROINTESTINAL SYMPTOM; HERB DRUG INTERACTION; HERBAL MEDICINE; HUMAN; LIVER INJURY; METHODOLOGY; NAUSEA; NEUROTOXICITY; OUTCOME ASSESSMENT; PATIENT SELECTION; PHOTOSENSITIVITY; QUALITATIVE RESEARCH; REVIEW; RHINOSINUSITIS; SCORING SYSTEM; SLURRED SPEECH; SYSTEMATIC REVIEW; UNCONSCIOUSNESS; UNSPECIFIED SIDE EFFECT; UNSTEADINESS; VALIDATION PROCESS;

CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; HUMANS; PHYTOTHERAPY; PLANT PREPARATIONS; RHINITIS; SINUSITIS;

EID: 33748986863     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2006.06.1254     Document Type: Review

References (45)

1. International Rhinosinusitis Advisory Board. Infectious rhinosinusitis in adults: classification, etiology, and management. Ear Nose Throat J 76 (1997) 5-22
2. Meltzer E.O., Hamilos D.L., Hadley J.A., et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 114 (2004) 155-212
3. Benninger M.S., Ferguson B.J., Hadley J.A., et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 129 (2003) S1-S32
4. Fokkens W., Lund V., Bachert C., et al. European position paper on rhinosinusitis and nasal polyps. Rhinol Suppl (2005) 1-87
5. Hamilos D.L. Chronic sinusitis. J Allergy Clin Immunol 106 (2000) 213-227
6. Blanc P.D., Trupin L., Earnest G., et al. Alternative therapies among adults with a reported diagnosis of asthma or rhinosinusitis: data from a population-based survey. Chest 120 (2001) 1461-1467
7. Krouse H.J., and Krouse J.H. Complementary therapeutic practices in patients with chronic sinusitis. Clin Excell Nurse Pract 3 (1999) 346-352
8. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
9. Berghorn, Langer W., and März R.W. Placebo-controlled, randomized double-blind clinical trial with Sinupret solution (SE) in addition to a basic therapy with antibiotics and decongestant nasal drops in acute sinusitis (1991), Bionorica GmbH, Neumarkt Unpublished clinical and biometrical report
10. Braum D., and März R.W. Open comparative study of Sinupret sugar coated tablets versus Fluimucil-Granulat (a mucolytic substance N-acetylcysteine granules) conducted in the army hospital in Giessen. Clinical and biometrical report (1990) (1992), Bionorica GmbH, Neumarkt Presented at the 4th National and 1st International Congress on Phytotherapy, Munich
11. Kraus P., and März R.W. Randomized comparative study of Sinupret sugar coated tablets versus Gelomyrtol forte for acute and chronic sinusitis (N = 134). Clinical and biometrical report (1991) (1992), Bionorica GmbH, Neumarkt Presented at the 4th National and 1st International Congress on Phytotherapy, Munich
12. Lecheler J., and März R.W. Double-blind, placebo-controlled clinical study in young asthmatic patients with chronic sinusitis (1986), Bionorica GmbH, Neumarkt Unpublished clinical and biometrical report
13. Simm K.J., Pape H.G., and März R.W. Double-blind study of Sinupret versus ambroxol (Mucosolvan) nasal drops for acute sinusitis (N = 160). Clinical and biometrical report (1991) (1992), Bionorica GmbH, Munich Presented at the 4th National and 1st International Congress on Phytotherapy, Neumarkt
14. Wahls M., and März R.W. Randomized double-blind controlled study of Sinupret solution versus ambroxol (Mucosolvan) nasal drops for acute sinusitis (N = 160). Clinical and biometrical report (1990) (1992), Bionorica GmbH, Munich Presented at the 4th National and 1st International Congress on Phytotherapy, Neumarkt
15. März R.W. Evaluation of a phytomedicine: clinical, pharmacological and toxicological data of Sinupret (1998), University of Utrecht, Netherlands
16. Federspil P., Wulkow R., and Zimmermann T. Effects of standardized Myrtol in therapy of acute sinusitis-results of a double-blind, randomized multicenter study compared with placebo. 705. Laryngorhinootologie 76 (1997) 23-27
17. Li C., Zhao Y., Liang C., et al. Observations of the curative effect with various liquid for postoperative irrigation of ESS of treating chronic sinusitis and nasal polyps. Lin Chuang Er Bi Yan Hou Ke Za Zhi 15 (2001) 53-54
18. Gabrielian E.S., Shukarian A.K., Goukasova G.I., et al. A double-blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis. Phytomedicine 9 (2002) 589-597
19. Tarasova G.D. The administration of sinupret in the treatment of acute sinusitis in children. Vestn Otorinolaringol 2 (2001) 46-48
20. Richstein A., and Mann W. Treatment of chronic sinusitis with Sinupret. Therapie der Gegenwart 119 (1980) 1055-1060
21. Liang C.-Y., Wen P., Zhen Y., et al. Multi-centre randomized controlled trial of bi yuan shu liquid on patients with chronic nasal sinusitis or nasal polyp after endoscopic sinus surgery. [Chinese]. Chin J Evid Based Med 4 (2004) 377-381
22. Zhu F., Zhang H., Zhang N., et al. Effects of taking the pingzhi tablets on cellular infiltration in tissues of nasal polyps. Lin Chuang Er Bi Yan Hou Ke Za Zhi 17 (2003) 468-469
23. Xiong Z.J., Zhang S.Q., and Fang R. Effect on the recovery process of nasal sinus mucosa with nasosinusitis and nasal polyps influenced by applying Chinese herbal preparation. Zhongguo Zhong Xi Yi Jie He Za Zhi 25 (2005) 707-709
24. Seltzer A.P. Adjunctive use of bromelains in sinusitis: a controlled study. Eye Ear Nose Throat Mon 46 (1967) 1281-1288
25. Ryan R.E. A double-blind clinical evaluation of bromelains in the treatment of acute sinusitis. Headache 7 (1967) 13-17
26. Taub S.J. The use of bromelains in sinusitis: a double-blind clinical evaluation. Eye Ear Nose Throat Mon 46 (1967) 361
27. Taub S.J. The use of Ananase in sinusitis: a study of 60 patients. Eye Ear Nose Throat Mon 45 (1966) 96
28. Neubauer N., and März R.W. Placebo-controlled, randomized double-blind clinical trial with Sinupret sugar coated tablets on the basis of a therapy with antibiotics and decongestant nasal drops in acute sinusitis. Phytomedicine 1 (1994) 177-181
29. Bogomilsky M., Garaschenko T.I., and Radtzig E.Y. Sinupret treatment in nonpurulent otitis media in children suffering from sinusitis (2002) 19th Congress of the European Rhinologic Society
30. Wu W.Q., Huang S.G., Ma Z., et al. Effects of irrigating solution of Sihuang on morphology and function of nasal mucosa following surgery for chronic sinusitis and nasal polyps. Di Yi Jun Yi Da Xue Xue Bao 25 (2005) 424-427
31. Kehrl W., Sonnemann U., and Dethlefsen U. Therapy for acute nonpurulent rhinosinusitis with cineole: results of a double-blind, randomized, placebo-controlled trial. Laryngoscope 114 (2004) 738-742
32. Zimmer M. Gezielte konservative Therapie der akuten Sinusitis in der HNO-Praxis. Therapiewoche 35 (1985) 4024-4028
33. Resch K.-L., and Ernst E. Research methodologies in complementary medicine: making sure it works. In: Ernst E. (Ed). Complementary medicine: an objective appraisal (1996), Butterworth, Oxford
34. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 263 (1990) 1385-1389
35. Egger M., Zellweger-Zähner T., Schneider M., et al. Language bias in randomised controlled trials published in English and German. Lancet 350 (1997) 326-329
36. Egger M., and Davey Smith G. Bias in location and selection of studies. BMJ 316 (1998) 61-66
37. Ernst E., and Pittler M. Alternative therapy bias. Nature 385 (1997) 480
38. Pittler M., Abbot N., Harkness E., et al. Location bias in controlled clinical trials of complementary/alternative therapies. J Clin Epidemiol 53 (2000) 485-489
39. Senior B.A., Kennedy D.W., Tanabodee J., et al. Long-term results of functional endoscopic sinus surgery 706. Laryngoscope 108 (1998) 151-157
40. Kuhn M.A. Herbal remedies: drug-herb interactions. Crit Care Nurse 22 (2002) 22-28 30, 32
41. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 136 (2002) 42-53
42. Chavez M.L., Jordan M.A., and Chavez P.I. Evidence-based drug-herbal interactions. Life Sci (2006)
43. Ernst E. Possible interactions between synthetic and herbal medicinal products. Perfusion 13 (2000) 4-15
44. Ernst E., and Pittler M.H. Risks associated with herbal medicinal products. Wien Med Wochenschr 152 (2002) 183-189
45. Pittler M.H., and Ernst E. Systematic review: hepatotoxic events associated with herbal medicinal products. Aliment Pharmacol Ther 18 (2003) 451-471